» Articles » PMID: 20394819

Mice with Altered Serotonin 2C Receptor RNA Editing Display Characteristics of Prader-Willi Syndrome

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2010 Apr 17
PMID 20394819
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

RNA transcripts encoding the 2C-subtype of serotonin (5HT(2C)) receptor undergo up to five adenosine-to-inosine editing events to encode twenty-four protein isoforms. To examine the effects of altered 5HT(2C) editing in vivo, we generated mutant mice solely expressing the fully-edited (VGV) isoform of the receptor. Mutant animals present phenotypic characteristics of Prader-Willi syndrome (PWS) including a failure to thrive, decreased somatic growth, neonatal muscular hypotonia, and reduced food consumption followed by post-weaning hyperphagia. Though previous studies have identified alterations in both 5HT(2C) receptor expression and 5HT(2C)-mediated behaviors in both PWS patients and mouse models of this disorder, to our knowledge the 5HT(2C) gene is the first locus outside the PWS imprinted region in which mutations can phenocopy numerous aspects of this syndrome. These results not only strengthen the link between the molecular etiology of PWS and altered 5HT(2C) expression, but also demonstrate the importance of normal patterns of 5HT(2C) RNA editing in vivo.

Citing Articles

Proteome profiling identifies circulating biomarkers associated with hepatic steatosis in subjects with Prader-Willi syndrome.

Pascut D, Giraudi P, Banfi C, Ghilardi S, Tiribelli C, Bondesan A Front Endocrinol (Lausanne). 2023; 14:1254778.

PMID: 38034016 PMC: 10684934. DOI: 10.3389/fendo.2023.1254778.


RNA modification: mechanisms and therapeutic targets.

Qiu L, Jing Q, Li Y, Han J Mol Biomed. 2023; 4(1):25.

PMID: 37612540 PMC: 10447785. DOI: 10.1186/s43556-023-00139-x.


Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases.

Broni E, Striegel A, Ashley C, Sakyi P, Peracha S, Velazquez M Int J Mol Sci. 2023; 24(7).

PMID: 37047766 PMC: 10095294. DOI: 10.3390/ijms24076795.


Molecular insights into the regulation of constitutive activity by RNA editing of 5HT serotonin receptors.

Gumpper R, Fay J, Roth B Cell Rep. 2022; 40(7):111211.

PMID: 35977511 PMC: 9422347. DOI: 10.1016/j.celrep.2022.111211.


Phylogenetic and Molecular Analyses Identify SNORD116 Targets Involved in the Prader-Willi Syndrome.

Baldini L, Robert A, Charpentier B, Labialle S Mol Biol Evol. 2021; 39(1).

PMID: 34893870 PMC: 8789076. DOI: 10.1093/molbev/msab348.


References
1.
Pin J, Joly C, Heinemann S, Bockaert J . Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J. 1994; 13(2):342-8. PMC: 394814. DOI: 10.1002/j.1460-2075.1994.tb06267.x. View

2.
Olaghere da Silva U, Morabito M, Canal C, Airey D, Emeson R, Sanders-Bush E . Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Front Neurosci. 2010; 4:26. PMC: 2858556. DOI: 10.3389/neuro.23.001.2010. View

3.
Xu Y, Jones J, Kohno D, Williams K, Lee C, Choi M . 5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis. Neuron. 2008; 60(4):582-9. PMC: 2631191. DOI: 10.1016/j.neuron.2008.09.033. View

4.
Berg K, Cropper J, Niswender C, Sanders-Bush E, Emeson R, Clarke W . RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol. 2001; 134(2):386-92. PMC: 1572953. DOI: 10.1038/sj.bjp.0704255. View

5.
Gallagher R, Pils B, AlBalwi M, Francke U . Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 2002; 71(3):669-78. PMC: 379204. DOI: 10.1086/342408. View